ABU DHABI, UAE — In the past 9 months, a surge of new trials related to the management of intracranial hemorrhage (ICH) has led the European Stroke Organisation (ESO) to delay issuing a planned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results